期刊文献+

四联疗法治疗消化性溃疡合并Hp感染的效果 被引量:1

Effect of Quadruple Therapy on Peptic Ulcer Complicated With Hp Infection
下载PDF
导出
摘要 目的分析四联疗法在消化性溃疡合并Hp(幽门螺杆菌)感染治疗中的应用效果。方法纳入本院2017年8月-2018年8月收治的消化性溃疡合并Hp感染患者90例,以"入院顺序奇偶性"作为分组原则,分对照组(接受三联疗法治疗,45例)、研究组(接受四联疗法治疗,45例),比较临床疗效、Hp根除率、溃疡消失时间、复发率。结果研究组临床总有效率、Hp根除率显著比对照组高,溃疡消失时间显著比对照组短,复发率显著比对照组低,P <0.05。结论四联疗法可有效改善消化性溃疡合并Hp感染患者病情,促进溃疡愈合,且复发率较低,疗效显著。 Objective To analyze the effect of quadruple therapy in the treatment of peptic ulcer complicated with Hp(Helicobacter pylori)infection. Methods Ninety patients with peptic ulcer complicated with Hp infection admitted to the hospital from August 2017 to August 2018 were divided into control group(45 cases received triple therapy) and research group(45 cases received quadruple therapy). The clinical efficacy,Hp eradication rate, ulcer disappearance time and recurrence rate were compared. Results The total clinical effective rate and Hp eradication rate of the study group were significantly higher than those of the control group,the ulcer disappearance time was significantly shorter than that of the control group, and the recurrence rate was significantly lower than that of the control group, P < 0.05. Conclusion Quadruple therapy can effectively improve the condition of peptic ulcer patients with Hp infection and promote ulcer healing. The recurrence rate is low and the curative effect is remarkable.
作者 牟文玲 MU Wenling(Department of Gastroenterology,Heilongjiang Provincial Hospital,Harbin Heilongjiang 150076,China)
出处 《中国卫生标准管理》 2019年第15期62-64,共3页 China Health Standard Management
关键词 三联疗法 四联疗法 消化性溃疡 幽门螺杆菌 治疗效果 复发率 triple therapy quadruple therapy peptic ulcer Helicobacter pylori therapeutic effect recurrence rate
  • 相关文献

参考文献13

二级参考文献127

  • 1Floriana Giorgio,Mariabeatrice Principi,Vincenzo De Francesco,Angelo Zullo,Giuseppe Losurdo,Alfredo Di Leo,Enzo Ierardi.Primary clarithromycin resistance to Helicobacter pylori : Is this the main reason for triple therapy failure?[J].World Journal of Gastrointestinal Pathophysiology,2013,4(3):43-46. 被引量:10
  • 2Kenneth Thorsen,Jon Arne Sreide,Jan Terje Kvaly,Tom Glomsaker,Kjetil Sreide.Epidemiology of perforated peptic ulcer:Age-and gender-adjusted analysis of incidence and mortality[J].World Journal of Gastroenterology,2013,19(3):347-354. 被引量:16
  • 3成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 4陈云华,汪春莲,谢云.幽门螺杆菌致病机制及益生菌防治作用的研究进展[J].世界华人消化杂志,2007,15(25):2690-2697. 被引量:52
  • 5En-ling Leung Ki,Francis K.L. Chan.Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice[J].Best Practice & Research Clinical Gastroenterology.2012(2)
  • 6Ghadir MR, Shafaghi A, Iranikhah A, et al. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease [J]. Turk J Gastroenterol, 2011, 22(1):1-5.
  • 7Liang J, Li J, Han Y, et al. Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial [J]. Helicobacter, 2012, 17(6): 458-465. DOI:10.1111/i.1523-5378.2012.00971.x.
  • 8De Smet J,Boussery K,De Cock P,et al.A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children[J].J Sep Sci,2010,33(6/7):939-947.
  • 9Borges KB,Sánchez AJ,Pupo MT,et al.Ultra-fast gradient lc method for omeprazole analysis using a monolithic column:assay development,validation,and application to the quality control of omeprazole enteric-coated pellets[J].J AOAC Int,2010,93(6):1811-1820.
  • 10Lee DY,Kim JW,Lee MG.Pharmacokinetic interaction between oltipraz and omeprazole in rats:competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1and3A2,and of omeprazole by oltipraz via CYP1A1/2,2D1/2,and 3A1/2[J].Eur J Pharm Sci,2007,32(4/5):328-339.

共引文献364

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部